Description
This product utilizes dendritic cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IRO29). We employs the AAV (CMV-mScarlet-c-Jun-HindIII) vector components and the SynExpress system of the single base pair Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
IRO29
Species Reactivity
Human
Cell Source
Dendritic cells
Sensor Gene
mScarlet
Promoter
CMV
Effector Gene
c-Jun
Insertion Sites
HindIII
Gene Modification
Knockout
Modification Domain
Single base pair
Carrier Type
AAV
Transformation Accuracy
0.93
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.